PharmaShots | Incisive News in 3 Shots

Subscribe Now

Mirikizumab

Dr. Lotus Mallbris Discusses Positive Results from the VIVID-1 P-III Study of Mirikizumab for the Treatment of Crohn's Disease in Adults

Dr. Lotus Mallbris Discusses Positive Results from the VIVID-1 P-III Study of Mirikizumab for the Treatment of Crohn's Disease in...

December 20, 2023

PharmaShots Interview: Eli Lilly's Dr. Lotus Mallbris Shares Insights on Mirikizumab

PharmaShots Interview: Eli Lilly's Dr. Lotus Mallbris Shares Insights on Mirikizumab

November 3, 2020

Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease

Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease

October 13, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us